I'll tell you once again. The best way to make money on thi stock is buy whenever this clown posts. This is the 7th time he has posted and the stock then makes a 20% run or more within a month. Look it up yourself, it's like clock work.
GIVE ME A HAWWWWWWWWWWWWWWWWW!
I notice that phony didn't address the FACT that he missed the run from $3.80 to $18 on OMER, but instead rambled on about some penny stock. It's obvious the guy is kicking himself for what may be one of the worst market calls on record. Screaming sell at $3.80 and then to $18 in less than a year. That's about as bad as you can get pcking stocks. I have looked at some of his other ranting on stocks and his track record is miserable pretty much across the board. Not to mention he's simply pathetic as a human being
HAW. Who cares about DRIO this is the OMER board loser and you #$%$ the bed on this one. Could have bought at $3.80 LOL---- NIce call!!!
...HAW!!!...you might want to check out what happened to DRIO!...I called that one four or five months ago when it was trading north of a buck a share!...it closed at 5 CENTS a share Friday!!!...oh, man!...talk about a good laugh!...it dropped from 60 CENTS to a NICKEL in only a WEEK!!...man, no doubt the suck...uhhhhh...shareholders were like deer caught in the headlights!...you might want to go over to the DRIO message board and review the events -- ya'know, help prepare you for your own day of reckoning!...HAW!!!...
I'm still up 150% plus in a year. How did your OMER trade work out? HAWWWW. You could have bought all you can at 3.80, you were right here on these boards. That has to hurt. But you still have that stock you bought that is up 100% since 2009 while the market is up 150%. Stick with index funds phonymd.
...about reimbursement for omidria in the 10-Q...it's too LONG to include all of it here, but the gist is:
"Obtaining reimbursement approval for any product from each government or third-party payor can be a time-consuming and costly process that will require the build-out of a sufficient staff or the engagement of third parties and could require us to provide supporting scientific, clinical and cost-effectiveness data for the use of our approved products to each payor. We can provide no assurances at this time regarding the cost-effectiveness and the amount, if any, or method of reimbursement for Omidria or any of our product candidates. Further, we can provide no assurance that the amounts, if any, reimbursed to surgical facilities for utilization of any of our surgery-related products, including Omidria, or product candidates or to surgeons for the administration and delivery of these products or product candidates will be considered adequate to justify the use of these products or product candidates."
...high-ho!...high-ho!... it's off to COA we go...HAW!...
...I've ever seen from gOMER was in the 10-Q:
"We expect our continued operating losses to result in an increase in the total amount of cash used in operations until at least the time that Omidria becomes cash flow positive, which may be in several years, if at all."
...HAW!!...yeah, would have been even MORE truthful if they had emphasized the "IF AT ALL"...HAW!...
Still holding, but it's been painful seeing the drop. I've considered selling if (and when) the price reaches $13.50. I'd be out with a 60% profit at that point. I was hoping for an even larger profit with this stock. Yahoo has the year out price at over $32, but that seems like a long shot right now.
I've been writing calls since May and making about 6-8% per month on my shares...so I can sit for a while...and collect premiums...so far so good..still long and collecting free dollars...don't like buying puts for insurance..if I think stock will tank ill get out...one reason to play the guessing/timing game..take the money n run...
Sentiment: Strong Buy
down 34% from July high, sucks being long right now. I Like the drug pipeline, but the price action had me concerned, sold 1/2 my position and purchased puts to protect the balance of my position. What are the rest of the suffering longs doing?
Now buying puts, I have to believe bad news is on the way. Management to quiet and selling continues.
Getting scary now, management needs to defend OMAR. We continue to sell off.
yes, open market purchase, not huge but about $100k is still pretty good. if they can successfully launch the drug and show some sales, then....